-Jeffrey N Myers Researcher Activity Profile

Research Author Detailed Information 

Jeffrey N Myers Publication Rate By Year

Jeffrey N Myers has published 7 paper(s) in 2006, 16 paper(s) in 2007, 2 paper(s) in 2008, for a total of 25 research publications in total.

Jeffrey N Jn Myers Author Information

LAST NAME: myers

FIRST NAME: Jeffrey N

INITIALS: jn

AFFILIATION:

Papers

Jeffrey N Myers's Publication Record

1. Concurrent cetuximab and bevacizumab therapy in a murine orthotopic model of anaplastic thyroid carcinoma. Year Published: 2007
The Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA.
2. Molecular analysis of anoikis resistance in oral cavity squamous cell carcinoma. Year Published: 2007
Department of Head and Neck Surgery, MD Anderson Cancer Center, University of Texas, 1515 Holcombe Blvd, Unit 441, Houston, TX 77030, USA.
3. The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck. Year Published: 2006
Department of Head and Neck Surgery, Unit 441, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.
4. Heart rate as a predictor of energy expenditure in people with spinal cord injury. Year Published: 2006
Spinal Cord Injury Center, Department of Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto, CA 94304, USA.
5. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer. Year Published: 2006
Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.
6. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma. Year Published: 2006
Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, 77030-4009, USA.
7. Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model. Year Published: 2006
Department of Head and Neck Surgery, Unit 441, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.
8. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Year Published: 2007
Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
9. Predicting Outcomes in Cardiovascular Disease: Added Value of Cardiopulmonary Exercise Testing: 72: 1:40 PM-2:10 PM. Year Published: 2007
VA Palo Alto HCS, Palo Alto, CA.
10. Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice. Year Published: 2007
Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.
11. Structural basis for depletion of heat shock protein 90 client proteins by deguelin. Year Published: 2007
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
12. Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping. Year Published: 2007
Departments of Experimental Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
13. The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model. Year Published: 2007
Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
14. The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium. Year Published: 2007
University of Wisconsin, Madison, WI 53792, USA. harari@humonc.wisc.edu
15. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model. Year Published: 2007
Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong, China.
16. Metastasis of squamous cell carcinoma of the oral tongue. Year Published: 2007
Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Unit 441, 1515 Holcombe Blvd, Houston, TX, 77030-4009, USA, dsano@mdanderson.org.
17. Molecular analysis of anoikis resistance in oral cavity squamous cell carcinoma. Year Published: 2007
Department of Head and Neck Surgery, MD Anderson Cancer Center, University of Texas, 1515 Holcombe Blvd, Unit 441, Houston, TX 77030, USA.
18. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma. Year Published: 2006
Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, 77030-4009, USA.
19. Metastasis of squamous cell carcinoma of the oral tongue. Year Published: 2007
Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Unit 441, 1515 Holcombe Blvd, Houston, TX 77030-4009, USA. dsano@mdanderson.org
20. Heart rate as a predictor of energy expenditure in people with spinal cord injury. Year Published: 2006
Spinal Cord Injury Center, Department of Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto, CA 94304, USA.
21. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. Year Published: 2007
Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 44, Houston, TX 77030-4009, USA.
22. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. Year Published: 2008
Department of Endocrine Neoplasia and Hormonal Disorders, Unit 435, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030-4009. sisherma@mdanderson.org.
23. Metastasis of squamous cell carcinoma of the oral tongue. Year Published: 2007
Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Unit 441, 1515 Holcombe Blvd, Houston, TX 77030-4009, USA. dsano@mdanderson.org
24. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. Year Published: 2007
Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 44, Houston, TX 77030-4009, USA.
25. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. Year Published: 2008
Department of Endocrine Neoplasia and Hormonal Disorders, Unit 435, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030-4009, USA.